Phospho-HGF R/c-MET (Y1234/Y1235) Affinity Purified PAb (25 UG)【科瑞奥博】

产品中心

当前位置：首页>产品中心

Phospho-HGF R/c-MET (Y1234/Y1235) Affinity Purified PAb (25 UG)

货号： AF2480-SP 基本售价： 2111.7 元规格： -

产品信息

概述
货号	AF2480-SP
别名	AUTS9; c-MET; EC 2.7.10; EC 2.7.10.1; hepatocyte growth factor receptor; HGF receptor; HGF/SF receptor; HGFR; Met (c-Met); met proto-oncogene (hepatocyte growth factor receptor); met proto-oncogene tyrosine kinase; MET; oncogene MET; Proto-oncogene c-Met; RCCP2; Scatter factor receptor; SF receptor; Tyrosine-protein kinase Met
全称	Hepatocyte Growth Factor Receptor
应用	Western Blot(0.5 µg/mL) Simple Western(5 µg/mL) Immunohistochemistry(5-15 µg/mL) Intracellular Staining by Flow Cytometry(2.5 µg/10⁶cells)
目标/特异性	Detects human and mouse HGF R/c-MET when phosphorylated at Y1234/Y1235 in Western blots.
使用方法	Western Blot: 0.5 µg/mL Simple Western: 5 µg/mL Immunohistochemistry: 5-15 µg/mL Intracellular Staining by Flow Cytometry: 2.5 µg/10⁶cells
来源	Reconstitute at 0.2 mg/mL in sterile PBS.
产品组分

性能
供应商	R&D Systems
Entrez Gene IDs	4233 (Human); 17295 (Mouse)
应用文献
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions. Dual MET/EGFR therapy leads to complete response and resistance prevention in a MET-amplified gastroesophageal xenopatient cohort Oncogene, 2016;0(0):. Species: Human Sample Type: Whole Tissue Application: IHC Paraffin-embedded Targeting MET kinase with the small-molecule inhibitor amuvatinib induces cytotoxicity in primary myeloma cells and cell lines. Authors: Phillip C, Zaman S, Shentu S, Balakrishnan K, Zhang J, Baladandayuthapani V, Taverna P, Redkar S, Wang M, Stellrecht C, Gandhi V J Hematol Oncol, 2013;6(0):92. Species: Human Sample Type: cells Application: Flow Protein signatures for classification and prognosis of gastric cancer a signaling pathway-based approach. Authors: Wang D, Ye F, Sun Y, Li W, Liu H, Jiang J, Zhang Y, Liu C, Tong W, Gao L, Sun Y, Zhang W, Seetoe T, Lee P, Suo J, Zhang DY Am. J. Pathol., 2011;179(4):1657-66. Species: Human Sample Type: Tissue Homogenates Application: Protein Array Development Combined inhibition of MET and EGFR suppresses proliferation of malignant mesothelioma cells. Authors: Kawaguchi K, Murakami H, Taniguchi T, Fujii M, Kawata S, Fukui T, Kondo Y, Osada H, Usami N, Yokoi K, Ueda Y, Yatabe Y, Ito M, Horio Y, Hida T, Sekido Y Carcinogenesis, 2009;30(7):1097-105. Species: Human Sample Type: Whole Tissue Application: IHC Paraffin-embedded Alternative proteolytic processing of hepatocyte growth factor during wound repair. Authors: Buchstein N, Hoffmann D, Smola H, Lang S, Paulsson M, Niemann C, Krieg T, Eming SA Am. J. Pathol., 2009;174(6):2116-28. Species: Human Sample Type: Whole Tissue Application: IHC Frozen
纯化方式	Antigen Affinity-purified
免疫原	Phosphopeptide containing human HGF R/c-MET Y1234/1235 sites
生物活性	Human, Mouse
标记	Unconjugated
溶解方法	Reconstitute at 0.2 mg/mL in sterile PBS.
背景	HGF R, also known as Met (from N-methyl-N’-nitro-N-nitrosoguanidine induced), is a glycosylated receptor tyrosine kinase that plays a central role in epithelial morphogenesis and cancer development. HGF R is synthesized as a single chain precursor which undergoes cotranslational proteolytic cleavage. This generates a mature HGF R that is a disulfide-linked dimer composed of a 50 kDa extracellular alpha chain and a 145 kDa transmembrane beta chain (1, 2). The extracellular domain (ECD) contains a seven bladed beta -propeller sema domain, a cysteine-rich PSI/MRS, and four Ig-like E-set domains, while the cytoplasmic region includes the tyrosine kinase domain (3, 4). Proteolysis and alternate splicing generate additional forms of human HGF R which either lack of the kinase domain, consist of secreted extracellular domains, or are deficient in proteolytic separation of the alpha and beta chains (5‑7). The sema domain, which is formed by both the alpha and beta chains of HGF R, mediates both ligand binding and receptor dimerization (3, 8). Ligand-induced tyrosine phosphorylation in the cytoplasmic region activates the kinase domain and provides docking sites for multiple SH2-containing molecules (9, 10). HGF stimulation induces HGF R downregulation via internalization and proteasome-dependent degradation (11). In the absence of ligand, HGF R forms noncovalent complexes with a variety of membrane proteins including CD44v6, CD151, EGF R, Fas, Integrin alpha 6/ beta 4, Plexins B1, 2, 3, and MSP R/Ron (12‑19). Ligation of one complex component triggers activation of the other, followed by cooperative signaling effects (12‑19). Formation of some of these heteromeric complexes is a requirement for epithelial cell morphogenesis and tumor cell invasion (12, 16, 17). Paracrine induction of epithelial cell scattering and branching tubulogenesis results from the stimulation of HGF R on undifferentiated epithelium by HGF released from neighboring mesenchymal cells (20). Genetic polymorphisms, chromosomal translocation, overexpression, and additional splicing and proteolytic cleavage of HGF R have been described in a wide range of cancers (1). Within the ECD, human HGF R shares 86%‑88% aa sequence identity with canine, mouse, and rat HGF R.
运输条件	Blue Ice
存放说明	4℃
参考文献	Birchmeier, C. et al. (2003) Nat. Rev. Mol. Cell Biol. 4:915. Corso, S. et al. (2005) Trends Mol. Med. 11:284. Gherardi, E. et al. (2003) Proc. Natl. Acad. Sci. 100:12039. Park, M. et al. (1987) Proc. Natl. Acad. Sci. 84:6379. Crepaldi, T. et al. (1994) J. Biol. Chem. 269:1750. Prat, M. et al. (1991) Mol. Cell. Biol. 12:5954. Rodrigues, G.A. et al. (1991) Mol. Cell. Biol. 11:2962. Kong-Beltran, M. et al. (2004) Cancer Cell 6:75. Naldini, L. et al. (1991) Mol. Cell. Biol. 11:1793. Ponzetto, C. et al. (1994) Cell 77:261. Jeffers, M. et al. (1997) Mol. Cell. Biol. 17:799. Orian-Rousseau, V. et al. (2002) Genes Dev. 16:3074. Klosek, S.K. et al. (2005) Biochem. Biophys. Res. Commun. 336:408. Jo, M. et al. (2000) J. Biol. Chem. 275:8806. Wang, X. et al. (2002) Mol. Cell 9:411. Trusolino, L. et al. (2001) Cell 107:643. Giordano, S. et al. (2002) Nat. Cell Biol. 4:720. Conrotto, P. et al. (2004) Oncogene 23:5131. Follenzi, A. et al. (2000) Oncogene 19:3041. Sonnenberg, E. et al. (1993) J. Cell Biol. 123:223.

参考图片

Detection of HGF R/c‑MET in pervanadate-treated MCF‑7 Human Cell Line by Flow Cytometry. MCF‑7 human breast cancer cell line was unstimulated (light orange open histogram) or treated with 100 μM pervanadate for 10 minutes (dark orange filled histogram), then stained with Rabbit Anti-Human/Mouse Phospho-HGF R/c‑MET (Y1234/Y1235) Antigen Affinity‑purified Polyclonal Antibody (Catalog # AF2480), or control antibody (Catalog # AB‑105‑C, blue open histogram), followed by Phycoerythrin-conjugated Anti-Rabbit IgG Secondary Antibody (Catalog # F0110). To facilitate intracellular staining, cells were fixed with paraformaldehyde and permeabilized with methanol.

HGF R/c-MET in Mouse Embryo. HGF R/c-MET was detected in immersion fixed frozen sections of mouse embryo (13 d.p.c.) using Rabbit Anti-Human/Mouse Phospho-HGF R/c-MET (Y1234/Y1235) Antigen Affinity-purified Polyclonal Antibody (Catalog # AF2480) at 15 µg/mL overnight at 4 °C. Tissue was stained using the Anti-Rabbit HRP-DAB Cell & Tissue Staining Kit (brown; Catalog # CTS005) and counterstained with hematoxylin (blue). View our protocol for Chromogenic IHC Staining of Frozen Tissue Sections.

Detection of Human Phospho-HGF R/c-MET (Y1234/Y1235) by Western Blot. Western blot shows Goat Anti-Human HGF R/c-MET Antigen Affinity-purified Polyclonal Antibody (Catalog #AF276) immunoprecipitate of MDA‑MB‑468 human breast cancer cell line untreated (-) or treated (+) with 100 μM pervanadate (PV) for 10 minutes. PVDF membrane was probed with 0.5 µg/mL of Rabbit Anti-Human/Mouse Phospho-HGF R/c‑MET (Y1234/Y1235) Antigen Affinity-purified Polyclonal Antibody (Catalog # AF2480), followed by HRP-conjugated Anti-Rabbit IgG Secondary Antibody (Catalog # HAF008). A specific band was detected for Phospho-HGF R/c‑MET (Y1234/Y1235) at approximately 145 kDa (as indicated). This experiment was conducted under reducing conditions and using Immunoblot Buffer Group 1.

Detection of Human Phospho-HGF R/c‑MET (Y1234/Y1235) by Simple Western^TM. Simple Western lane view shows lysates of MDA‑MB‑468 human breast cancer cell line untreated (-) or treated (+) with 100 µM Pervanadate (PV) for 10 minutes, loaded at 0.2 mg/mL. A specific band was detected for HGF R/c‑MET at approximately 156 kDa (as indicated) using 5 µg/mL of Rabbit Anti-Human/Mouse Phospho-HGF R/c‑MET (Y1234/Y1235) Antigen Affinity-purified Polyclonal Antibody (Catalog # AF2480). This experiment was conducted under reducing conditions and using the 12-230 kDa separation system.